Cara stock price chart

CARA Stock Analysis: Price, Forecast, and News

Cara Therapeutics, Inc. (CARA) Stock Price, Quote, History ... Find the latest Cara Therapeutics, Inc. (CARA) stock quote, history, news and other vital information to help you with your stock trading and investing. CARA - Cara Therapeutics Stock Price - Barchart.com Cara Therapeutics (CARA) Reports Q4 Loss, the beginning of the period. Thus, Weighted Alpha is a measure of one-year growth with an emphasis on the most recent price activity. Chart Snapshot. (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: CARA Stock Price | Cara Therapeutics Inc. Stock Quote (U.S ...

Cara Therapeutics CHART | CARA Chart | Markets Insider

TradingView India. View live CARA THERAPEUTICS INC chart to track its stock's price action. Find market predictions, CARA financials and market news. CARA Cara Therapeutics — Stock Price and Discussion ... Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. CARA -- Is Its Stock Price A Worthy Investment? Learn More. CARA Stock Summary. Of note is the ratio of Cara Therapeutics Inc's sales and general administrative expense to its total operating expenses; only 6.26% of US stocks have a lower such ratio. CARA's price/sales ratio is 37.51; that's higher than the P/S ratio of 96.19% of US stocks. Cara Therapeutics Inc. Stock Price (CARA) | Barron's

Apr 02, 2020 · Stock quote and company snapshot for CARA THERAPEUTICS INC (CARA), including profile, stock chart, recent news and events, analyst opinions, and research reports.

Get breaking news and analysis on Cara Therapeutics, Inc. (CARA) stock, price quote and chart, trading and investing tools. Date, Share Price, Change. 03 Jan 2020, 11.70, 0.00. 02 Jan 2020, 11.70, 0.00. 31 Dec 2019, 11.70, 0.00. 30 Dec 2019, 11.70, 0.00. 27 Dec 2019, 11.70, 0.00. Returns 5-year. Matinas Biopharma Holdings Inc MTNB. $0.6. Price (USD). -46.9 %. Returns 1-year. 0%. Returns 5-year. Lineage Cell Therapeutics Inc LCTX. IPO Status Public Stock Symbol NASDAQ:CARA Company Type For Profit Charts can be found on various organization profiles and on Hubs pages, based on  19 Mar 2020 Cara Therapeutics (CARA) Stock Price Movement in past 50 Days is also the price on which most charts are based; the chart updates with 

Apr 03, 2020 · Price Definition. The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).

CARA Stock | CARA THERAPEUTICS Stock Price Today | Markets ... CARA: Get the latest Cara Therapeutics stock price and detailed information including CARA news, historical charts and realtime prices. Cara Therapeutics, Inc. (CARA) stock price, quote, history ... Cara Therapeutics (CARA) Reports Q4 Loss, Misses Revenue Estimates. Cara (CARA) delivered earnings and revenue surprises of 1.61% and -19.13%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Get breaking news and analysis on Cara Therapeutics, Inc. (CARA) stock, price quote and chart, trading and investing tools.

CARA Stock Summary. Of note is the ratio of Cara Therapeutics Inc's sales and general administrative expense to its total operating expenses; only 6.26% of US stocks have a lower such ratio. CARA's price/sales ratio is 37.51; that's higher than the P/S ratio of 96.19% of US stocks. Cara Therapeutics Inc. Stock Price (CARA) | Barron's

CARA: Get the latest Cara Therapeutics stock price and detailed information including CARA news, historical charts and realtime prices. Cara Therapeutics, Inc. (CARA) stock price, quote, history ... Cara Therapeutics (CARA) Reports Q4 Loss, Misses Revenue Estimates. Cara (CARA) delivered earnings and revenue surprises of 1.61% and -19.13%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock? CARA Historical Stock Prices Cara Therapeutics (CARA) has the following price history information. Looking back at CARA historical stock prices for the last five trading days, on March 13, 2020, CARA opened at $11.50, traded as high as $12.00 and as low as $10.39, and closed at $11.53. Trading volume was a total of 708.90K shares. CARA Stock Analysis: Price, Forecast, and News CARA Stock Analysis Overview . What this means: Cara Therapeutics (CARA) gets an Overall Rank of 71, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.